LEADER 01057nam0-22003851i-450- 001 990003972050403321 005 20090123150644.0 010 $a0-262-65040-1 035 $a000397205 035 $aFED01000397205 035 $a(Aleph)000397205FED01 035 $a000397205 100 $a20031010d1994----km-y0itay50------ba 101 0 $aeng 105 $aa---a---001yy 200 1 $a<>course in game theory$fM.J. Osborne, A. Rubinstein 210 $aCambridge$cThe MIT Press$dc1994 215 $aXV, 352 p.$d23 cm 610 0 $aCibernetica 610 0 $aTeoria dei giochi 610 0 $aTeoria degli automi 610 0 $aIntelligenza artificiale 676 $a658 700 1$aOsborne,$bMartin J.$0140512 701 1$aRubinstein,$bAriel$f<1951- >$0120823 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003972050403321 952 $a02 49 C 63$b8039$fFINBN 952 $a8-382$bD.S.F. 9124$fFI1 959 $aFINBN 959 $aFI1 962 $a91-XX 996 $aCourse in game theory$945083 997 $aUNINA LEADER 03630nam 22006375 450 001 9910300214703321 005 20200705212552.0 010 $a3-642-31220-9 024 7 $a10.1007/978-3-642-31220-5 035 $a(CKB)3710000000412202 035 $a(EBL)2096704 035 $a(SSID)ssj0001501370 035 $a(PQKBManifestationID)11840161 035 $a(PQKBTitleCode)TC0001501370 035 $a(PQKBWorkID)11522623 035 $a(PQKB)10959809 035 $a(DE-He213)978-3-642-31220-5 035 $a(MiAaPQ)EBC2096704 035 $a(PPN)186030126 035 $a(EXLCZ)993710000000412202 100 $a20150504d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBreast Cancer Biology for the Radiation Oncologist /$fedited by Jonathan Strauss, William Small, Gayle E. Woloschak 205 $a1st ed. 2015. 210 1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2015. 215 $a1 online resource (94 p.) 225 1 $aRadiation Oncology 300 $aDescription based upon print version of record. 311 $a3-642-31219-5 320 $aIncludes bibliographical references. 327 $aBiological subtypes of breast cancer -- Oncogene amplification and Herceptin -- Current clinical use of genetic profiling -- Biology of DCIS and progression to invasive disease -- Cancer Stem Cells and Radiotherapy -- Genetic basis of normal tissue radiosensitivity and late toxicity -- Genetic syndromes and radiotherapy in breast cancer -- Experimental therapies in breast cancer. 330 $aBreast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible. 410 0$aRadiation Oncology 606 $aRadiotherapy 606 $aOncology 606 $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aRadiotherapy. 615 0$aOncology. 615 14$aRadiotherapy. 615 24$aOncology. 676 $a616.9944906 702 $aStrauss$b Jonathan$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSmall$b William$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aWoloschak$b Gayle E$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910300214703321 996 $aBreast Cancer Biology for the Radiation Oncologist$91760487 997 $aUNINA